Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cinacalcet. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR known ✓ | P41180 | 5/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 3/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 3/20 | 1.00 |
| ▸ | DRD3 | P35462 | 3/20 | 1.00 |
| ▸ | HTR2C | P28335 | 3/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 1/20 | 1.00 |
| ▸ | GLRA1 | P23415 | 1/20 | 1.00 |
| ▸ | AVPR2 | P30518 | 1/20 | 1.00 |
| ▸ | HRH1 | P35367 | 1/20 | 1.00 |
| ▸ | MC3R | P41968 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cinacalcet SCHEMBL1901469 | 1.00 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL71876 | 1.00 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL29373418 | 1.00 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL3227084 | 1.00 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL30371982 | 1.00 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL1179140 | 0.99 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL195640 | 0.99 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL29364854 | 0.99 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL30482673 | 0.99 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C | |
| Cinacalcet SCHEMBL29363135 | 0.99 | CASR (1.00) | CASRADRA2CSLC6A4DRD3HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | claimed |
| US-20240074944-A1 | PECVD COATED PHARMACEUTICAL PACKAGING | OAKTREE FUND ADMINISTRATION, LLC | 2024-03-07 | — | — | US | claimed |
| US-20240050420-A1 | NANOMEDICINES FOR TREATMENT OF DISEASE | CHAPMAN UNIVERSITY | 2024-02-15 | — | — | US | claimed |
| US-20230303305-A1 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | OAKTREE FUND ADMINISTRATION, LLC | 2023-09-28 | — | — | US | claimed |
| EP-4247316-A1 | POLYMER VIALS HAVING STANDARD EXTERNAL DIMENSIONS AND REDUCED INTERNAL VOLUME | SiO2 Medical Products, Inc. (US) | 2023-09-27 | — | — | EP | claimed |
| US-20230277415-A1 | POLYMER VIALS HAVING STANDARD EXTERNAL DIMENSIONS AND REDUCED INTERNAL VOLUME | SIO2 MEDICAL PRODUCTS, INC. | 2023-09-07 | — | — | US | claimed |
| US-20230263957-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | OAKTREE FUND ADMINISTRATION, LLC | 2023-08-24 | — | — | US | claimed |
| US-11724860-B2 | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus | SIO2 MEDICAL PRODUCTS, INC. (US) | 2023-08-15 | — | — | US | claimed |
| CN-113499343-B | Topical compositions | MC2疗法有限公司 | 2023-07-21 | — | — | CN | claimed |
| US-11684546-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, INC. (US) | 2023-06-27 | — | — | US | claimed |
| EP-4188996-A1 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | SiO2 Medical Products, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| EP-4168068-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SiO2 Medical Products, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| EP-3578175-B1 | RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND | AMGEN INC (US) | 2022-11-30 | — | — | EP | claimed |
| US-20220244247-A1 | PECVD COATED PHARMACEUTICAL PACKAGING | OAKTREE FUND ADMINISTRATION, LLC | 2022-08-04 | — | — | US | claimed |
| WO-2022109619-A1 | POLYMER VIALS HAVING STANDARD EXTERNAL DIMENSIONS AND REDUCED INTERNAL VOLUME | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220161969-A1 | PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS | OAKTREE FUND ADMINISTRATION, LLC | 2022-05-26 | — | — | US | claimed |
| US-11298293-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-04-12 | — | — | US | claimed |
| US-20260139378-A1 | PULSED PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION PROCESS, SYSTEM, AND COATED VESSELS | SIO2 MEDICAL PRODUCTS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12629477-B2 | Vacuum insertion methods for inserting lubricant free syringe stoppers and a system for assembling same | W. L. GORE & ASSOCIATES, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4741655-A2 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SiO2 Medical Products, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12623813-B2 | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus | SIO2 MEDICAL PRODUCTS, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4168068-B1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SIO2 MEDICAL PRODUCTS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4724059-A1 | USE OF CALCIUM SENSING RECEPTOR ANTAGONISTS FOR TREATING OCULAR DISORDERS | The Regents of University of California (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4081210-B1 | PHARMACEUTICAL COMPOSITION OF CASR MODULATORS AND METHODS AND USES THEREOF | LUPIN LTD (IN) | 2026-04-15 | — | — | EP | disclosed |
| EP-4392105-B1 | INJECTOR DEVICE COMPONENT SURFACE MODIFICATION | GORE & ASS (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12594290-B2 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | Sanifit Therapeutics S.A. (ES) | 2026-04-07 | — | — | US | disclosed |
| EP-4182001-B1 | IMPLANTABLE CRANIAL MEDICAL DEVICE | BIOGEN MA INC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12583971-B2 | Biosourced gelling polyamides | POLYMEREXPERT SA (FR) | 2026-03-24 | — | — | US | disclosed |
| US-12558304-B2 | Metal oxide particle ester dispersions including polyesters having a broad molecular weight distribution | INOLEX INVESTMENT CORPORATION (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4695276-A1 | ACTIVATORS OF THE COLD STRESS RESPONSE AND USES THEREOF | University of Iceland (IS) | 2026-02-18 | — | — | EP | disclosed |
| EP-3436005-B1 | L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID (TNCA) FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH MUTATED OR ABNORMAL CALCIUM SENSING RECEPTOR PROTEIN (CASR) | UNIV GEORGIA STATE RES FOUND (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20260014058-A1 | METHODS AND SYSTEMS FOR COATING, CLEANING, AND INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | SIO2 MEDICAL PRODUCTS INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12514985-B2 | Method of inserting a lubricant free stopper into a lubricant free barrel or a lubricant free cartridge tube and a system for assembling same | W. L. GORE & ASSOCIATES, INC. (US) | 2026-01-06 | — | — | US | disclosed |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2026-01-01 | — | — | US | disclosed |
| US-20250387487-A1 | COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT | HERON THERAPEUTICS INC (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4637881-A1 | LOW INSERTION FORCE SYRINGE STOPPERS, ASSEMBLIES, AND ASSOCIATED METHODS | W. L. Gore & Associates, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4635577-A2 | WATER-RESISTANT AND/OR PHOTOPROTECTIVE COMPOSITIONS COMPRISING NON-SOLUBILIZED MICRONIZED WAXES | Lubrizol Advanced Materials, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250319008-A1 | HAIR COMPOSITIONS USES AND METHODS THEREOF | FUNCTION INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250302853-A1 | IP AND IP ANALOGS DOSAGE REGIMENS FOR THE TREATMENT OF ECTOPIC CALCIFICATIONS | Sanifit Therapeutics S.A. (ES) | 2025-10-02 | — | — | US | disclosed |
| EP-4044992-B1 | WATER-RESISTANT AND/OR PHOTOPROTECTIVE COMPOSITIONS COMPRISING NON-SOLUBILIZED MICRONIZED WAXES | LUBRIZOL ADVANCED MAT INC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250281372-A1 | POWDERS HAVING IMPROVED DISPERSABILITY AND USE THEREOF IN COMPOSITIONS AND ARTICLES OF MANUFACTURE | COLOR TECHNIQUES INC (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250281481-A1 | NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILTY OF 5-HT RECEPTOR AGONISTS | LDN Pharma Limited (GB) | 2025-09-11 | — | — | US | disclosed |
| EP-4281046-B1 | NALTREXONE COMPOSITIONS | LDN PHARMA LTD (GB) | 2025-09-10 | — | — | EP | disclosed |
| EP-3402554-B1 | SYRINGE PLUNGER ASSEMBLIES | GORE & ASS (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4583975-A2 | FERMENTED ARNICA OIL IN PERSONAL CARE APPLICATIONS | HLB90067, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250161458-A1 | COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT | HERON THERAPEUTICS, INC. | 2025-05-22 | — | — | US | disclosed |
| WO-2025099741-A1 | PROCESS FOR THE PREPARATION OF NITROSAMINE FREE CINACALCET AND SALTS THEREOF | MEGAFINE PHARMA (P) LTD. (IN) | 2025-05-15 | — | — | WO | disclosed |
| EP-3730134-B1 | MEDICINAL COMPOSITION FOR PREVENTING OR TREATING SECONDARY HYPERPARATHYROIDISM UNDER MAINTENANCE DIALYSIS | EA PHARMA CO LTD (JP) | 2025-05-14 | — | — | EP | disclosed |
| EP-4544094-A1 | METHODS AND SYSTEMS FOR COATING, CLEANING, AND INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | SiO2 Medical Products, LLC (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20250121137-A1 | RESHAPING OF INJECTOR DEVICE STOPPER FEATURES | GORE & ASS (US) | 2025-04-17 | — | — | US | disclosed |
| CN-119731370-A | Method and system for coating a drug container, cleaning a drug container and checking a drug container for particles and defects | 二氧化硅医疗产品公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-4525814-A1 | POWDER TREATMENT, MANUFACTURING METHOD, COMPOSITION AND USE | Sensient Cosmetic Technologies (FR) | 2025-03-26 | — | — | EP | disclosed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025055641-A1 | PHARMACEUTICAL COMPOSITIONS OF POLYMERIC MICELLAR CINACALCET, AND METHODS OF PREPARATION AND USE THEREOF | HANGZHOU SHIXI PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) | 2025-03-20 | — | — | WO | disclosed |
| EP-4039295-B1 | MEDICAL DELIVERY DEVICES WITH INHIBITED OXYGEN PERMEATION | GORE & ASS (US) | 2025-03-12 | — | — | EP | disclosed |
| US-12246169-B2 | Medical delivery devices having low lubricant hydrophobic syringe barrels | W.L. GORE & ASSOCIATES, INC. (US) | 2025-03-11 | — | — | US | disclosed |
| US-12239606-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-04 | — | — | US | disclosed |
| EP-3838262-B1 | INJECTABLE AND BIODEGRADABLE POLYMER FORMULATIONS FOR CONTROLLED RELEASE OF BIOACTIVE AGENTS | GORE & ASS (US) | 2025-02-12 | — | — | EP | disclosed |
| US-20250041217-A1 | Compositions | VITUX GROUP AS (NO) | 2025-02-06 | — | — | US | disclosed |
| US-20240424219-A1 | THROUGH BARREL PROCESSING FOR INJECTOR DEVICE COMPONENTS | GORE & ASS (US) | 2024-12-26 | — | — | US | disclosed |
| US-12171219-B2 | Bag for easy drainage and manipulation | W. L. GORE & ASSOCIATES (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240417138-A1 | PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS | SIO2 MEDICAL PRODUCTS, LLC | 2024-12-19 | — | — | US | disclosed |
| WO-2024254561-A1 | USE OF CALCIUM SENSING RECEPTOR ANTAGONISTS FOR TREATING OCULAR DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-12 | — | — | WO | disclosed |
| CN-119079992-A | Layered porous biochar prepared from heavy bio-oil and preparation method and application thereof | 南京林业大学 | 2024-12-06 | — | — | CN | disclosed |
| US-20240382685-A1 | INJECTOR DEVICE COMPONENT SURFACE MODIFICATION | GORE & ASS (US) | 2024-11-21 | — | — | US | disclosed |
| CN-118983049-A | Low-calcium nursing system for renal osteosis of hemodialysis patient and operation method | 重庆医科大学 | 2024-11-19 | — | — | CN | disclosed |
| EP-4461794-A2 | MULTIFUNCTIONAL COMPOUND MIXTURES COMPRISING MULTIPLE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2024-11-13 | — | — | EP | disclosed |
| US-20240350739-A1 | FORMATION OF INJECTOR DEVICE STOPPER FEATURES | GORE & ASS (US) | 2024-10-24 | — | — | US | disclosed |
| WO-2024213728-A1 | ACTIVATORS OF THE COLD STRESS RESPONSE AND USES THEREOF | UNIVERSITY OF ICELAND (IS) | 2024-10-17 | — | — | WO | disclosed |
| US-20240335615-A1 | Automated System for Assembling A Pre-Filled Syringe | W. L. GORE & ASSOCIATES, INC. (US) | 2024-10-10 | — | — | US | disclosed |
| US-12090305-B2 | Medical delivery device with laminated stopper | W. L. GORE & ASSOCIATES, INC. (US) | 2024-09-17 | — | — | US | disclosed |
| US-12083322-B2 | Medical delivery device with laminated stopper | W. L. GORE & ASSOCIATES, INC. (US) | 2024-09-10 | — | — | US | disclosed |
| US-20240293447-A1 | Materials and Methods for Prevention and Treatment of Diarrhea and Inflammation in the Gastrointestinal Tract | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2024-09-05 | — | — | US | disclosed |
| US-20240295502-A1 | METHODS FOR INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | OAKTREE FUND ADMINISTRATION, LLC | 2024-09-05 | — | — | US | disclosed |
| US-20240285866-A1 | INJECTOR DEVICE STOPPER WITH ACTIVATABLE LAYER | GORE & ASS (US) | 2024-08-29 | — | — | US | disclosed |
| CN-115210238-B | Substituted aminoquinolones as dgkα inhibitors for immune activation | 拜耳公司 | 2024-08-27 | — | — | CN | disclosed |
| US-12070469-B2 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | Sanifit Therapeutics S.A. (ES) | 2024-08-27 | — | — | US | disclosed |
| US-20240269039-A1 | AUTHENTICATION/TRACKING OF PHARMACEUTICAL PACKAGES USING WAVE-SHIFTING MARKER CRYSTALS | INTELLIGENT MATERIAL SOLUTIONS, INC. | 2024-08-15 | — | — | US | disclosed |
| US-20240252756-A1 | Medical Delivery Devices Having Low Lubricant Syringe Barrels | W. L. GORE & ASSOCIATES, INC. (US) | 2024-08-01 | — | — | US | disclosed |
| US-12036395-B2 | Automated system for assembling a pre-filled syringe | W.L. GORE & ASSOCIATES, INC. | 2024-07-16 | — | — | US | disclosed |
| EP-4392106-A1 | RESHAPING OF INJECTOR DEVICE STOPPER FEATURES | W. L. Gore & Associates, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-4392103-A1 | FORMATION OF INJECTOR DEVICE STOPPER FEATURES | W. L. Gore & Associates, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-4392105-A1 | INJECTOR DEVICE COMPONENT SURFACE MODIFICATION | W. L. Gore & Associates, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-4392104-A1 | THROUGH BARREL PROCESSING FOR INJECTOR DEVICE COMPONENTS | W. L. Gore & Associates, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024137753-A1 | LOW INSERTION FORCE SYRINGE STOPPERS, ASSEMBLIES, AND ASSOCIATED METHODS | W. L. GORE & ASSOCIATES, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-4389176-A1 | LOW INSERTION FORCE SYRINGE STOPPERS, ASSEMBLIES, AND ASSOCIATED METHODS | W. L. Gore & Associates, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240189184-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SIO2 MEDICAL PRODUCTS, LLC | 2024-06-13 | — | — | US | disclosed |
| US-20240173244-A1 | METAL OXIDE PARTICLE ESTER DISPERSIONS INCLUDING POLYESTERS HAVING A BROAD MOLECULAR WEIGHT DISTRIBUTION AND PROCESSES FOR PREPARING THE SAME | INOLEX INVESTMENT CORPORATION (US) | 2024-05-30 | — | — | US | disclosed |
| US-11986494-B2 | Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| EP-4358943-A1 | NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILITY OF 5-HT RECEPTOR AGONISTS | LDN Pharma Limited (GB) | 2024-05-01 | — | — | EP | disclosed |
| CN-117940182-A | Processing of injector device components through a syringe | W.L.戈尔及同仁股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240124650-A1 | BIOSOURCED GELLING POLYAMIDES | POLYMEREXPERT SA (FR) | 2024-04-18 | — | — | US | disclosed |
| CN-117881444-A | Reshaping of injector device stopper features | W.L.戈尔及同仁股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-117881445-A | Injector device stopper with activatable layer | W.L.戈尔及同仁股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-117881447-A | Formation of injector device stop features | W.L.戈尔及同仁股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20240115487-A1 | Water-resistant and/or photoprotective Compositions Comprising Non-Solubilized Micronized Waxes | LUBRIZOL ADVANCED MATERIALS, INC. | 2024-04-11 | — | — | US | disclosed |
| EP-4346737-A1 | AUTHENTICATION/TRACKING OF PHARMACEUTICAL PACKAGES USING WAVE-SHIFTING MARKER CRYSTALS | SiO2 Medical Products, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20240108583-A1 | NALTREXONE COMPOSITIONS | LDN Pharma Limited (GB) | 2024-04-04 | — | — | US | disclosed |
| US-11931553-B2 | Medical delivery devices having low lubricant syringe barrels | W. L. GORE & ASSOCIATES, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| WO-2024054608-A2 | FERMENTED ARNICA OIL IN PERSONAL CARE APPLICATIONS | HLB90067, Inc. (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20240074944-A1 | PECVD COATED PHARMACEUTICAL PACKAGING | OAKTREE FUND ADMINISTRATION, LLC | 2024-03-07 | — | — | US | disclosed |
| US-20240066042-A1 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | LABORATORIS SANIFIT, S.L. (ES) | 2024-02-29 | — | — | US | disclosed |
| US-20240050420-A1 | NANOMEDICINES FOR TREATMENT OF DISEASE | CHAPMAN UNIVERSITY | 2024-02-15 | — | — | US | disclosed |
| CN-117545472-A | Naltrexone compositions | LDN制药有限公司 | 2024-02-09 | — | — | CN | disclosed |
| EP-4313212-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SiO2 Medical Products, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20240034985-A1 | COMPOSITIONS FROM A BACTERIAL ORGANISM AND USES THEREOF | LIBERTY BIOSECURITY, LLC | 2024-02-01 | — | — | US | disclosed |
| US-11884446-B2 | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus | SIO2 MEDICAL PRODUCTS, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230414878-A1 | FORMULATIONS, METHODS, AND PRE-FILLED INJECTION DEVICES WITHOUT FATTY ACID PARTICLES | W. L. GORE & ASSOCIATES, INC. | 2023-12-28 | — | — | US | disclosed |
| WO-2023250385-A1 | METHODS AND SYSTEMS FOR COATING, CLEANING, AND INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | SIO2 MEDICAL PRODUCTS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| US-11844837-B2 | Compositions of a polyorthoester and an organic acid excipient | HERON THERAPEUTICS, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| EP-4045566-B1 | BIOSOURCED GELLING POLYAMIDES | POLYMEREXPERT SA (FR) | 2023-12-06 | — | — | EP | disclosed |
| EP-4281046-A1 | NALTREXONE COMPOSITIONS | LDN Pharma Limited (GB) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023222764-A1 | POWDER TREATMENT, MANUFACTURING METHOD, COMPOSITION AND USE | SENSIENT COSMETIC TECHNOLOGIES (FR) | 2023-11-23 | — | — | WO | disclosed |
| US-20230340670-A1 | PULSED PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION PROCESS, SYSTEM, AND COATED VESSELS | OAKTREE FUND ADMINISTRATION, LLC | 2023-10-26 | — | — | US | disclosed |
| US-20230338249-A1 | Compositions Comprising (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-10-26 | — | — | US | disclosed |
| EP-4264240-A1 | METHODS FOR INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | SiO2 Medical Products, Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230321413-A1 | IMPLANTABLE CRANIAL MEDICAL DEVICE | CEREBRAL THERAPEUTICS, INC. (US) | 2023-10-12 | — | — | US | disclosed |
| EP-4252788-A2 | MEDICAL DELIVERY DEVICES HAVING LOW LUBRICANT SYRINGE BARRELS | W. L. Gore & Associates, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20230303305-A1 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | OAKTREE FUND ADMINISTRATION, LLC | 2023-09-28 | — | — | US | disclosed |
| US-20230301886-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-09-28 | — | — | US | disclosed |
| US-20230293410-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-09-21 | — | — | US | disclosed |
| US-20230293403-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-09-21 | — | — | US | disclosed |
| EP-4243769-A2 | FORMULATIONS, METHODS, AND PRE-FILLED INJECTION DEVICES WITHOUT FATTY ACID PARTICLES | W. L. Gore & Associates, Inc. (US) | 2023-09-20 | — | — | EP | disclosed |
| US-20230285253-A1 | COSMETIC OIL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-09-14 | — | — | US | disclosed |
| US-11752099-B2 | Injectable and biodegradable polymer formulations for controlled release of bioactive agents | W. L. GORE & ASSOCIATES, INC. | 2023-09-12 | — | — | US | disclosed |
| US-11746379-B2 | Gene fusions and gene variants associated with cancer | Life Technologies Corporation (US) | 2023-09-05 | — | — | US | disclosed |
| US-20230270102-A1 | BAG FOR EASY DRAINAGE AND MANIPULATION | GORE & ASS (US) | 2023-08-31 | — | — | US | disclosed |
| EP-4234753-A2 | COATED PACKAGING | SiO2 Medical Products, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4233940-A2 | MEDICAL DELIVERY DEVICE WITH LAMINATED STOPPER | W. L. Gore & Associates, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4229161-A1 | CLEANING ARTICLE WITH PREFERENTIAL COATING | The Procter & Gamble Company (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11730685-B2 | Skin composition booster oil | CONOPCO, INC., D/B/A UNILEVER | 2023-08-22 | — | — | US | disclosed |
| CN-116615245-A | Composition comprising a lipophilic compound and one or more (bio) alkanediols | 西姆莱斯股份公司 | 2023-08-18 | — | — | CN | disclosed |
| EP-4216909-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-08-02 | — | — | EP | disclosed |
| CN-116529227-A | Method for efficiently preparing (bio) -alkanediol | 西姆莱斯股份公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-113499343-B | Topical compositions | MC2疗法有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-20230227919-A1 | GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER | Life Technologies Corporation (US) | 2023-07-20 | — | — | US | disclosed |
| US-RE49569-E1 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20230201467-A1 | A METHOD OF INSERTING A LUBRICANT FREE STOPPER INTO A LUBRICANT FREE BARREL OR A LUBRICANT FREE CARTRIDGE TUBE AND A SYSTEM FOR ASSEMBLING SAME | GORE & ASS (US) | 2023-06-29 | — | — | US | disclosed |
| CN-116332809-A | Process for producing alkylamine derivative and intermediate for production thereof | 味之素株式会社 | 2023-06-27 | — | — | CN | disclosed |
| US-11684546-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| CN-116322610-A | Moisturizing antibacterial composition | 联合利华知识产权控股有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4197021-A2 | PULSED PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION PROCESS AND SYSTEM | SiO2 Medical Products, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| EP-2971228-B1 | COATED PACKAGING | SI02 MEDICAL PRODUCTS INC (US) | 2023-06-21 | — | — | EP | disclosed |
| EP-4188996-A1 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | SiO2 Medical Products, Inc. (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-4182001-A1 | IMPLANTABLE CRANIAL MEDICAL DEVICE | CEREBRAL THERAPEUTICS, INC. (US) | 2023-05-24 | — | — | EP | disclosed |
| US-20230150727-A1 | PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS | OAKTREE FUND ADMINISTRATION, LLC | 2023-05-18 | — | — | US | disclosed |
| US-20230140221-A1 | VACUUM INSERTION METHODS FOR INSERTING LUBRICANT FREE SYRINGE STOPPERS AND A SYSTEM FOR ASSEMBLING SAME | W. L. GORE & ASSOCIATES, INC. | 2023-05-04 | — | — | US | disclosed |
| EP-4168068-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SiO2 Medical Products, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-111840264-B | Use of cisacana for inhibiting biological activity of gram-positive bacteria | 华中科技大学协和深圳医院 | 2023-04-07 | — | — | CN | disclosed |
| EP-4153280-A1 | A METHOD OF INSERTING A LUBRICANT FREE STOPPER INTO A LUBRICANT FREE BARREL OR A LUBRICANT FREE CARTRIDGE TUBE AND A SYSTEM FOR ASSEMBLING SAME | W.L. Gore & Associates Inc. (US) | 2023-03-29 | — | — | EP | disclosed |
| EP-4153321-A1 | TOPICAL COMPOSITIONS, PROCESS OF LARGE-SCALE MANUFACTURE, AND METHOD OF USE | Progeneron, LLC (US) | 2023-03-29 | — | — | EP | disclosed |
| CN-115814202-A | Medical delivery device with inhibited oxygen permeation | W.L.戈尔及同仁股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2023027729-A1 | INJECTOR DEVICE COMPONENT SURFACE MODIFICATION | W. L. GORE & ASSOCIATES, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| WO-2023027725-A1 | RESHAPING OF INJECTOR DEVICE STOPPER FEATURES | W. L. GORE & ASSOCIATES, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| WO-2023027722-A1 | INJECTOR DEVICE STOPPER WITH ACTIVATABLE LAYER | W. L. GORE & ASSOCIATES, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| WO-2023027727-A1 | THROUGH BARREL PROCESSING FOR INJECTOR DEVICE COMPONENTS | W. L. GORE & ASSOCIATES, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| WO-2023027724-A1 | FORMATION OF INJECTOR DEVICE STOPPER FEATURES | W. L. GORE & ASSOCIATES, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-4137181-A1 | MEDICAL DELIVERY DEVICE WITH LAMINATED STOPPER | W. L. Gore & Associates, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| US-20230049917-A1 | Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof | LUPIN LIMITED (IN) | 2023-02-16 | — | — | US | disclosed |
| US-20230039255-A1 | COATED POWDERS HAVING HIGH PHOTOSTABILITY | NANOPHASE TECH CORPORATION (US) | 2023-02-09 | — | — | US | disclosed |
| US-11564963-B2 | Topical compositions, process of large-scale manufacture, and method of use | PROGENERON, LLC (US) | 2023-01-31 | — | — | US | disclosed |
| EP-4121144-A1 | VACUUM INSERTION METHODS FOR INSERTING LUBRICANT FREE SYRINGE STOPPERS AND A SYSTEM FOR ASSEMBLING SAME | W. L. Gore & Associates, Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| CN-112312946-B | Medical delivery device with inhibited oxygen permeation | W.L.戈尔及同仁股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-111321177-B | Method for synthesizing cinacalcet intermediate (R) -1- (1-naphthyl) ethylamine by enzyme method | 泰州学院 | 2023-01-03 | — | — | CN | disclosed |
| CN-115536556-A | Process for producing alkylamine derivative and intermediate for producing the same | 味之素株式会社 | 2022-12-30 | — | — | CN | disclosed |
| US-20220411495-A1 | POSITIVE ALLOSTERIC MODULATORS OF THE CALCIUM-SENSING RECEPTOR | UNIVERSITY OF COPENHAGEN (DK) | 2022-12-29 | — | — | US | disclosed |
| WO-2022269264-A1 | NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILITY OF 5-HT RECEPTOR AGONISTS | LDN Pharma Limited (GB) | 2022-12-29 | — | — | WO | disclosed |
| EP-4103142-A1 | COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2022-12-21 | — | — | EP | disclosed |
| WO-2022251230-A1 | AUTHENTICATION/TRACKING OF PHARMACEUTICAL PACKAGES USING WAVE-SHIFTING MARKER CRYSTALS | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-12-01 | — | — | WO | disclosed |
| EP-3600431-B1 | A COMBINATION FOR USE IN THE TREATMENT OF LUNG CANCER | LDN PHARMA LTD (GB) | 2022-11-23 | — | — | EP | disclosed |
| US-11499054-B2 | Coated powders having high photostability | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2022-11-15 | — | — | US | disclosed |
| EP-4081210-A1 | PHARMACEUTICAL COMPOSITION OF CASR MODULATORS AND METHODS AND USES THEREOF | Lupin Limited (IN) | 2022-11-02 | — | — | EP | disclosed |
| EP-3651728-B1 | FREEZE DRIED ACTIVE COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2022-10-26 | — | — | EP | disclosed |
| US-20220331567-A1 | IMPLANTABLE CRANIAL MEDICAL DEVICE | CEREBRAL THERAPEUTICS, INC. (US) | 2022-10-20 | — | — | US | disclosed |
| CN-115210238-A | Substituted aminoquinolones as DGK alpha inhibitors for immune activation | 拜耳公司 | 2022-10-18 | — | — | CN | disclosed |
| WO-2022211865-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| EP-3558243-B1 | PERSONAL CARE COMPOSITIONS COMPRISING POORLY SOLUBLE COMPOUNDS | UNILEVER IP HOLDINGS B V (NL) | 2022-10-05 | — | — | EP | disclosed |
| EP-4065603-A1 | POSITIVE ALLOSTERIC MODULATORS OF THE CALCIUM-SENSING RECEPTOR | VIB VZW (BE) | 2022-10-05 | — | — | EP | disclosed |
| US-20220296817-A1 | MEDICAL DELIVERY DEVICE WITH LAMINATED STOPPER | GORE & ASS (US) | 2022-09-22 | — | — | US | disclosed |
| US-11439757-B2 | Medical delivery device with laminated stopper | W. L. GORE & ASSOCIATES, INC. (US) | 2022-09-13 | — | — | US | disclosed |
| EP-2961858-B1 | COATED SYRINGE. | SI02 MEDICAL PRODUCTS INC (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-4045566-A1 | BIOSOURCED GELLING POLYAMIDES | Polymerexpert SA (FR) | 2022-08-24 | — | — | EP | disclosed |
| EP-4044992-A1 | WATER-RESISTANT AND/OR PHOTOPROTECTIVE COMPOSITIONS COMPRISING NON-SOLUBILIZED MICRONIZED WAXES | Lubrizol Advanced Materials, Inc. (US) | 2022-08-24 | — | — | EP | disclosed |
| US-20220257866-A1 | MEDICAL DELIVERY DEVICE WITH LAMINATED STOPPER | GORE & ASS (US) | 2022-08-18 | — | — | US | disclosed |
| US-20220249521-A1 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | Sanifit Therapeutics S.A. (ES) | 2022-08-11 | — | — | US | disclosed |
| EP-4039295-A1 | MEDICAL DELIVERY DEVICES WITH INHIBITED OXYGEN PERMEATION | W. L. Gore & Associates, Inc. (US) | 2022-08-10 | — | — | EP | disclosed |
| US-11406765-B2 | Controlling the uniformity of PECVD deposition | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| US-20220244247-A1 | PECVD COATED PHARMACEUTICAL PACKAGING | OAKTREE FUND ADMINISTRATION, LLC | 2022-08-04 | — | — | US | disclosed |
| WO-2022157385-A1 | NALTREXONE COMPOSITIONS | LDN Pharma Limited (GB) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022133359-A1 | METHODS FOR INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022122885-A1 | COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| US-11344473-B2 | Coated packaging | SiO2Medical Products, Inc. (US) | 2022-05-31 | — | — | US | disclosed |
| CN-114555049-A | Water-repellent and/or light-protective composition comprising a non-solubilising micronized wax | 路博润先进材料公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20220161969-A1 | PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS | OAKTREE FUND ADMINISTRATION, LLC | 2022-05-26 | — | — | US | disclosed |
| WO-2022099963-A1 | FUSION PROTEIN FOR IMPROVING ORAL ADMINISTRATION STABILITY OF POLYPEPTIDE DRUG, AND APPLICATION THEREOF | 安徽新熙盟生物科技有限公司 | 2022-05-19 | — | — | WO | disclosed |
| WO-2022104388-A2 | FORMULATIONS, METHODS, AND PRE-FILLED INJECTION DEVICES WITHOUT FATTY ACID PARTICLES | W. L. GORE & ASSOCIATES, INC. (US) | 2022-05-19 | — | — | WO | disclosed |
| CN-110357165-B | Process for preparing mixed metal compounds | 欧普科爱尔兰环球控股有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-20220142958-A1 | MEDICINAL COMPOSITION HAVING EXCELLENT STABILITY | EA PHARMA CO., LTD. (JP) | 2022-05-12 | — | — | US | disclosed |
| CN-110099722-B | Cosmetic composition with reduced odor | 联合利华知识产权控股有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-11311508-B2 | Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis | EA PHARMA CO., LTD. (JP) | 2022-04-26 | — | — | US | disclosed |
| US-20220117458-A1 | CLEANING ARTICLE WITH PREFERENTIAL COATING | THE PROCTER & GAMBLE COMPANY | 2022-04-21 | — | — | US | disclosed |
| WO-2022082192-A1 | CLEANING ARTICLE WITH PREFERENTIAL COATING | THE PROCTER & GAMBLE COMPANY (US) | 2022-04-21 | — | — | WO | disclosed |
| EP-3261605-B2 | CYCLOOLEFIN POLYMER CONTAINER WITH A SCRATCH RESISTANT AND ANTI-STATIC COATING | SIO2 MEDICAL PRODUCTS INC (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-3984577-A1 | SYRINGE STOPPERING SYSTEM | W.L. Gore & Associates Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-107592807-B | Cycloolefin polymer container having a scratch-resistant and antistatic coating | SIO2医药产品公司 | 2022-04-15 | — | — | CN | disclosed |
| US-11298293-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-04-12 | — | — | US | disclosed |
| WO-2022063596-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-03-31 | — | — | WO | disclosed |
| US-20220087900-A1 | POLYMER PROCESS BAGS AND METHODS FOR MANUFACTURING THE SAME | OAKTREE FUND ADMINISTRATION, LLC | 2022-03-24 | — | — | US | disclosed |
| US-11278471-B2 | Storage bag for containing therapeutic compounds | W. L. GORE & ASSOCIATES, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| WO-2022036147-A2 | PULSED PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION PROCESS, SYSTEM, AND COATED VESSELS | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
| CN-108992432-B | Nonwoven membrane for use as a drug delivery system | 加泰罗尼亚理工大学 | 2022-02-11 | — | — | CN | disclosed |
| EP-3950058-A1 | PHARMACEUTICAL COMPOSITION HAVING FAVORABLE STABILITY | EA Pharma Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-114026067-A | Peptide mimetics for the treatment of coronavirus and picornavirus infections | 埃默里大学 | 2022-02-08 | — | — | CN | disclosed |
| WO-2022020512-A1 | BAG FOR EASY DRAINAGE AND MANIPULATION | W. L. GORE & ASSOCIATES, INC. (US) | 2022-01-27 | — | — | WO | disclosed |
| WO-2022020512-A1 | BAG FOR EASY DRAINAGE AND MANIPULATION | W. L. GORE & ASSOCIATES, INC. (US) | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (31 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12623813-B2 | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus | VEGFA, ITGAV, F8 | CASR 493/4885ADRA2C 1849/4885SLC6A4 885/4885 |
| US-12594290-B2 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | IP6K2, IP6K3, IPMK | CASR 67/4885ADRA2C 1287/4885SLC6A4 3154/4885 |
| US-11844837-B2 | Compositions of a polyorthoester and an organic acid excipient | OTC, OAT, SLCO2A1 | CASR 3428/4885ADRA2C 2671/4885SLC6A4 1742/4885 |
| US-20230338249-A1 | Compositions Comprising (Bio)-Alkanediols | OR51E2, OR10J3, ALOX5 | CASR 3600/4885ADRA2C 699/4885SLC6A4 3791/4885 |
| US-20240066042-A1 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | ATP6V1B1, PROC, GC | CASR 43/4885ADRA2C 1680/4885SLC6A4 1208/4885 |
| US-20260139378-A1 | PULSED PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION PROCESS, SYSTEM, AND COATED VESSELS | VEGFA, FLT4, FLT1 | CASR 405/4885ADRA2C 1699/4885SLC6A4 1583/4885 |
| US-20230293403-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | CUTA, TRPA1, SMURF2 | CASR 961/4885ADRA2C 581/4885SLC6A4 3924/4885 |
| US-20240124650-A1 | BIOSOURCED GELLING POLYAMIDES | PUF60, PARG, CUTA | CASR 4172/4885ADRA2C 4334/4885SLC6A4 4881/4885 |
| US-12070469-B2 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | PPIP5K2, IPMK, IP6K3 | CASR 90/4885ADRA2C 3377/4885SLC6A4 3264/4885 |
| US-20240108583-A1 | NALTREXONE COMPOSITIONS | CYP24A1, CYP2R1, VDR | CASR 333/4885ADRA2C 187/4885SLC6A4 775/4885 |
| US-20250161458-A1 | COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT | OTC, OAT, SLCO2A1 | CASR 3428/4885ADRA2C 2671/4885SLC6A4 1742/4885 |
| US-11564963-B2 | Topical compositions, process of large-scale manufacture, and method of use | POLR1C, POLN, CUTA | CASR 4882/4885ADRA2C 1682/4885SLC6A4 4884/4885 |
| US-20220249521-A1 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | ATP6V1B1, PROC, GC | CASR 43/4885ADRA2C 1680/4885SLC6A4 1208/4885 |
| US-20250281481-A1 | NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILTY OF 5-HT RECEPTOR AGONISTS | VDR, OPRD1, HTR1A | CASR 77/4885ADRA2C 75/4885SLC6A4 44/4885 |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | TAS2R40, BRDT, APOB | CASR 1921/4885ADRA2C 1576/4885SLC6A4 1827/4885 |
| US-20230293410-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | TRPA1, CUTA, OR51E2 | CASR 1443/4885ADRA2C 405/4885SLC6A4 3515/4885 |
| US-20230049917-A1 | Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof | CASR, CALCR, PTH1R | CASR 1/4885ADRA2C 245/4885SLC6A4 1678/4885 |
| US-12629477-B2 | Vacuum insertion methods for inserting lubricant free syringe stoppers and a system for assembling same | VMP1, TRAM1, PIEZO1 | CASR 4439/4885ADRA2C 4286/4885SLC6A4 1956/4885 |
| US-20230285253-A1 | COSMETIC OIL COMPOSITION | CUTA, SQLE, ALOX15 | CASR 4522/4885ADRA2C 1115/4885SLC6A4 4515/4885 |
| US-20240173244-A1 | METAL OXIDE PARTICLE ESTER DISPERSIONS INCLUDING POLYESTERS HAVING A BROAD MOLECULAR WEIGHT DISTRIBUTION AND PROCESSES FOR PREPARING THE SAME | POLD1, SBDS, EED | CASR 4793/4885ADRA2C 4845/4885SLC6A4 3019/4885 |
| US-11311508-B2 | Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis | PTH1R, PTMS, REN | CASR 13/4885ADRA2C 674/4885SLC6A4 4392/4885 |
| US-12583971-B2 | Biosourced gelling polyamides | ACSL1, OGG1, PUF60 | CASR 4763/4885ADRA2C 3024/4885SLC6A4 4883/4885 |
| US-11730685-B2 | Skin composition booster oil | CUTA, ALOX12, ALOX15 | CASR 4484/4885ADRA2C 855/4885SLC6A4 4124/4885 |
| US-20250387487-A1 | COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT | OPRD1, OPRM1, SIGMAR1 | CASR 2996/4885ADRA2C 560/4885SLC6A4 234/4885 |
| US-20260014058-A1 | METHODS AND SYSTEMS FOR COATING, CLEANING, AND INSPECTING PHARMACEUTICAL CONTAINERS FOR PARTICLES AND DEFECTS | CASK, VEGFA, KDR | CASR 1035/4885ADRA2C 308/4885SLC6A4 4664/4885 |
| US-20240115487-A1 | Water-resistant and/or photoprotective Compositions Comprising Non-Solubilized Micronized Waxes | PWWP2B, CYP2W1, POLB | CASR 4603/4885ADRA2C 1484/4885SLC6A4 4408/4885 |
| US-20250302853-A1 | IP AND IP ANALOGS DOSAGE REGIMENS FOR THE TREATMENT OF ECTOPIC CALCIFICATIONS | PPIP5K2, IPMK, IP6K3 | CASR 90/4885ADRA2C 3377/4885SLC6A4 3264/4885 |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | MEN1, MYO1G, IL2 | CASR 1098/4885ADRA2C 2177/4885SLC6A4 3278/4885 |
| US-20220142958-A1 | MEDICINAL COMPOSITION HAVING EXCELLENT STABILITY | UGT2B7, TPMT, CEL | CASR 2569/4885ADRA2C 478/4885SLC6A4 4457/4885 |
| US-12558304-B2 | Metal oxide particle ester dispersions including polyesters having a broad molecular weight distribution | POLD1, RPL7, EEF1D | CASR 4802/4885ADRA2C 4108/4885SLC6A4 3604/4885 |
| US-20250319008-A1 | HAIR COMPOSITIONS USES AND METHODS THEREOF | CUTA, KRT18, NACA | CASR 1796/4885ADRA2C 4569/4885SLC6A4 2605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.